AmbioPharm, Inc. Expanding Aiken County Operations

COLUMBIA, S.C. – AmbioPharm, Inc. (APi), a company that specializes in the manufacturing of peptides and the development of generic drugs, is expanding its existing Aiken County operations. The company is investing $18.8 million in the expansion and will create 100 new jobs over the next five years. Governor Nikki Haley said AmbioPharm‘s decision to build its headquarters in South Carolina is another example of how our workforce and business-friendly environment continue to attract companies to our state. “This $18 million investment and the 100 new jobs it will create illustrates AmbioPharm‘s continued commitment to Aiken County and to South Carolina as a whole,” Haley said APi started their business in South Carolina in 2007, by establishing its company headquarters and downstream manufacturing operations in a 10,000-square-foot facility in the North Augusta Industrial Park. That same year, APi also opened its Shanghai, China operations, which focuses on synthesis, as well as the research and development of pharmaceutical products. In 2014, the company made major facility expansions by adding 10,000 square feet in North Augusta and 18,000 square feet in Shanghai. Between the two facilities, the company now employs more than 200 workers. To expand its Aiken County operations, APi is planning to construct additional manufacturing suites and a new world headquarters building on the existing 32 acres that APi owns. In total, the new additions will add approximately 40,000 square feet to the company‘s existing facility at 1024 Dittman Court, North Augusta, South Carolina. The expansion in North Augusta is anticipated to be completed by the third quarter of 2018.